Cory Renauer
Cory Renauer is a contributing Healthcare Analyst at The Motley Fool, covering publicly traded companies across pharmaceuticals, biotechnology, and medical devices. Prior to The Motley Fool, Cory was an educator in Thailand and a laboratory technician for the American Red Cross. He holds a B.S. in Biology from Oakland University. Fun fact: Cory has a collection of novelty socks featuring famous stock market symbols and iconic investor quotes.
Recent Articles by Cory Renauer

Jul 22, 2025
by Cory Renauer
2 Beaten-Down Dividend Growth Stocks to Buy on the Dip

Jul 22, 2025
by Cory Renauer
Meet the Biotech Stock That Rocketed 775% Higher

Jul 17, 2025
by Cory Renauer
Is Johnson & Johnson a Good Dividend Stock to Buy Now?

Jul 3, 2025
by Cory Renauer
Is Pfizer Stock a Yield Trap?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.